{"id":"W1531562711","doi":"10.1111/j.1464-410x.2009.09086.x","title":"Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head‐to‐head placebo‐controlled trial","year":2009,"lang":"en","type":"article","venue":"British Journal of Urology","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"Pfizer","keywords":"Tolterodine; Tolerability; Overactive bladder; Placebo; Medicine; Urology; Clinical endpoint; Randomized controlled trial; Urinary incontinence; Internal medicine; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001881294,0.001252786,0.004782039,0.0004437592,0.0003702602,0.0009772549,0.001115046,0.00238541,0.007910718],"category_scores_gemma":[0.002204509,0.0007063787,0.001984433,0.0003953618,0.001137847,0.001040155,0.0003096522,0.0020137,0.0008367072],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004946742,"about_ca_system_score_gemma":0.0008994619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006442116,"about_ca_topic_score_gemma":0.001178764,"domain_scores_codex":[0.9991512,0.0004601586,0.00008931528,0.0001399448,0.0000717767,0.00008750377],"domain_scores_gemma":[0.9987464,0.0005464675,0.0002671395,0.00007692779,0.00007738496,0.0002856361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9878093,0.002309454,0.0001121443,0.0006661292,0.0005418966,0.00002143184,0.00002016588,0.00007792952,0.001100755,0.0000340504,0.0001316454,0.00717499],"study_design_scores_gemma":[0.951561,0.0468011,0.0006703484,0.00003105743,0.0003416512,0.00001867067,0.00001191945,0.0001145626,0.000190409,0.00003642965,0.000215556,0.000007214409],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750721,0.01710779,0.0007000895,0.000599995,0.0008872752,0.003107151,0.0008534181,0.0001326527,0.001539568],"genre_scores_gemma":[0.9813653,0.008918689,0.001237699,0.0008588159,0.001012916,0.003501612,0.0006770076,0.00002291851,0.002405212],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007910718,"threshold_uncertainty_score":0.02646405,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04778961473786036,"score_gpt":0.3923191753739758,"score_spread":0.3445295606361155,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}